Skip to content
SB
Company

Updated:

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001106838, and its...

Overview

Sonnet BioTherapeutics Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001106838, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-12-16, it reported annual revenue of USD 1,000,000; net income of USD -16,011,487; total assets of USD 14,884,558 for the fiscal period ended 2025-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Sonnet BioTherapeutics Holdings, Inc.
Former names in filing history
Chanticleer Holdings, Inc. (2005-05-10 to 2020-03-31); TULVINE SYSTEMS INC (2000-03-07 to 2005-03-31)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Princeton, NJ, United States
Incorporated in
DE
Fiscal year end
September 30
SEC CIK
0001106838

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2025USD$1.0M-$16.0M$14.9M$5.1M-$12.8M
FY2024USD$18,626-$7.4M$2.8M$149,456-$8.6M
FY2023USD$147,805-$18.8M$5.4M—-$21.3M
FY2022USD$349,943-$29.7M$5.8M—-$27.7M

FY2022. Operating cash flow: shown as originally filed; later filings report different values for the same periods.

Recent SEC filings

FormFiledPeriodFiling
10-K/A10-K/A
10-K10-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
DEF 14ADEF 14A
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Sonnet BioTherapeutics Holdings, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Sonnet BioTherapeutics Holdings, Inc. | Company | Altss